Document is current
Any future updates will be listed below
-
Authors
Bliddal, Henning
Beier, Jannie
Hartkopp, Andreas
Conaghan, Philip G.
Henriksen, Marius
-
Funding
Funding for this research was provided by:
OAK Foundation (OCAY-18–774-OFIL, OCAY-18–774-OFIL)
Contura International A/S
National Institute for Health and Care Research (NIHR) Leeds, Biomedical Research Centre
Copenhagen University
- License Information
-
More Information
Article History
Received: 1 November 2023
Accepted: 21 April 2024
First Online: 2 May 2024
Declarations
:
: The study protocol was approved by the local Health Research Ethics committee (ref.no: H-19031685) and the Danish Health authorities before any study related activities were undertaken.Patients provided informed consent for participation in the study and results that cannot identify the patient to be published.
: HB and MH have received travelling grants from Contura International A/S. HB has received consulting fees, honoraria, research or institutional support, educational grants, equipment, services or expenses from Abbott, Abbvie, Amgen, AstraZeneca, Aventis, Axellus, Bristol Myers Squibb, Cambridge Weight Plan, Contura, Dansk Droge, Eurovita, Ferrosan, GlaxoSmithKline, Hoechst, LEO, Eli Lilly, Lundbeck, MSD, Mundipharma, Norpharma, NOVO, NutriCare, Nycomed, Pfizer, Pharmacia, Pierre-Fabre, Proctor&Gamble, Rhone-Poulenc, Roche, Roussel, Schering-Plough, Searle, Serono, UCB, Wyeth. MH has received consulting fees from the Thuasne Group. PGC has received consulting or speaker fees from AbbVie, AstraZeneca, Eli Lilly, Galapagos, GlaxoSmithKline, Grunenthal, Janssen, Levicept, Merck, Novartis, Pfizer, Regeneron, Stryker and UCB. JB and AH have reported no conflicts.
